Alcon Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?
ALCON has fifty-two approved drugs.
There are four US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.
There are sixty-six patent family members on ALCON drugs in twenty-eight countries and fifty-seven supplementary protection certificates in thirteen countries.
Summary for Alcon
| International Patents: | 66 |
| US Patents: | 4 |
| Tradenames: | 43 |
| Ingredients: | 36 |
| NDAs: | 52 |
| Patent Litigation for Alcon: | See patent lawsuits for Alcon |
| PTAB Cases with Alcon as patent owner: | See PTAB cases with Alcon as patent owner |
Drugs and US Patents for Alcon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | MAXIDEX | dexamethasone sodium phosphate | OINTMENT;OPHTHALMIC | 083342-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Alcon Pharma | ZADITOR | ketotifen fumarate | SOLUTION/DROPS;OPHTHALMIC | 021066-002 | Oct 19, 2006 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
| Alcon Pharms Ltd | NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate; neomycin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062714-001 | Jul 21, 1986 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Alcon Pharms Ltd | ZADITOR | ketotifen fumarate | SOLUTION/DROPS;OPHTHALMIC | 077200-001 | Sep 2, 2008 | OTC | No | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Alcon Pharms Ltd | SULFACETAMIDE SODIUM | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 089068-001 | May 5, 1987 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Alcon | STATROL | neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 062339-001 | Nov 30, 1984 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon
Paragraph IV (Patent) Challenges for ALCON drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.00% | ➤ Subscribe | 2008-11-28 |
| ➤ Subscribe | Ophthalmic Solution | 0.03% | ➤ Subscribe | 2004-12-23 |
International Patents for Alcon Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2826725 | See Plans and Pricing |
| Slovenia | 2722035 | See Plans and Pricing |
| Mexico | 2011013107 | See Plans and Pricing |
| Japan | 6017956 | See Plans and Pricing |
| Slovenia | 3045164 | See Plans and Pricing |
| Chile | 2010000634 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1920764 | C01920764/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002 |
| 2365988 | LUC00061 | Luxembourg | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 2957286 | LUC00094 | Luxembourg | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 2957286 | 132019000000021 | Italy | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721 |
| 1280520 | C01280520/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012 |
| 0720599 | CR 2014 00050 | Denmark | See Plans and Pricing | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
